HR阳性HER2低表达晚期乳腺癌治疗研究 进展:2024 ASCO会议乳腺癌研究热点解读.

Saved in:
Bibliographic Details
Title: HR阳性HER2低表达晚期乳腺癌治疗研究 进展:2024 ASCO会议乳腺癌研究热点解读.
Alternate Title: Research Progress in Treatment of HR-Positive/HER 2-Low Advanced Breast Cancer: Interpretation of Breast Cancer Research Hotspots in 2024 ASCO.
Authors: 马艺文1, 徐君南1, 孙涛1 jianong@126.com
Source: Cancer Research on Prevention & Treatment. 2/25/2025, Vol. 52 Issue 2, p98-102. 5p.
Database: Academic Search Ultimate
Description
ISSN:10008578
DOI:10.3971/j.issn.1000-8578.2025.24.1033